Completed PHASE1 INTERVENTIONAL 1-arm NCT03425084

Genetic Variation in Organic Cation Transport 1 (OCT1) and Its Significance for Morphine Pharmacokinetics

Sponsor: Danish Council for Independent Research

Conditions Morphine Organic Cation Transporter 1

Interventions Morphine

Updated 6 times since 2018 Last updated: Jun 24, 2020 Started: Jun 1, 2018 Primary completion: Feb 7, 2020 Completion: Feb 7, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03425084, this PHASE1 trial focuses on Morphine and Organic Cation Transporter 1 and remains completed. Sponsored by Danish Council for Independent Research, it has been updated 6 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jul 2020 — Jan 2021 [monthly]

Completed PHASE1

Status: Not Yet Recruiting → Completed
Jun 2018 — Jul 2020 [monthly]

Not Yet Recruiting PHASE1

▶ Show 1 earlier version

Mar 2018 — Jun 2018 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Danish Council for Independent Research
Region of Southern Denmark
The Faculty of Health Sciences SDU
University of Southern Denmark

Data source: University of Southern Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Esbjerg, Denmark
• Odense, Denmark